Molina Healthcare, Inc (NYSE:MOH – Get Free Report) insider Jeff Barlow sold 17,811 shares of the firm’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $186.12, for a total value of $3,314,983.32. Following the transaction, the insider directly owned 67,175 shares of the company’s stock, valued at $12,502,611. This represents a 20.96% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.
Molina Healthcare Price Performance
MOH opened at $184.78 on Friday. The stock has a 50-day moving average price of $156.96 and a 200-day moving average price of $158.90. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.63 and a quick ratio of 1.63. The firm has a market cap of $9.63 billion, a PE ratio of 54.67 and a beta of 0.85. Molina Healthcare, Inc has a 1 year low of $121.06 and a 1 year high of $327.68.
Molina Healthcare (NYSE:MOH – Get Free Report) last posted its quarterly earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.78. The firm had revenue of $10.80 billion during the quarter, compared to analyst estimates of $10.91 billion. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.Molina Healthcare’s quarterly revenue was down 3.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.08 EPS. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Sell-side analysts predict that Molina Healthcare, Inc will post 5.23 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Molina Healthcare
Analyst Upgrades and Downgrades
A number of equities analysts have weighed in on MOH shares. Wells Fargo & Company boosted their target price on Molina Healthcare from $141.00 to $159.00 and gave the stock an “equal weight” rating in a research report on Monday, April 27th. The Goldman Sachs Group cut their price objective on Molina Healthcare from $167.00 to $124.00 and set a “neutral” rating for the company in a research note on Wednesday, February 11th. Mizuho cut their price objective on Molina Healthcare from $220.00 to $180.00 and set an “outperform” rating for the company in a research note on Thursday, March 12th. Cantor Fitzgerald boosted their price target on Molina Healthcare from $144.00 to $209.00 and gave the stock a “neutral” rating in a report on Monday, May 11th. Finally, Wall Street Zen raised Molina Healthcare from a “sell” rating to a “hold” rating in a report on Saturday, May 2nd. Three research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, Molina Healthcare presently has a consensus rating of “Hold” and a consensus target price of $174.53.
Read Our Latest Research Report on Molina Healthcare
Molina Healthcare Company Profile
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
See Also
- Five stocks we like better than Molina Healthcare
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
